EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Nano-Carbon Biointerfaces in Biosensors for Cancer: A Scoping Review Mapping the Transition from Proof-of-Concept to Translational Applicability (2024–2026)

Barbara R Geraldino iD, Nilséia A Barbosa iD, Priscila M Galdino, Eduardo X F G Migon, Danielle Godoy, Tatiana Cunha iD, Fernando M Araújo-Moreira iD

Biosensors · 21.07.2026 · 16 (7) · 395

DOI: 10.3390/bios16070395 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Biosensors, online erschienen am 21.07.2026. Verfasst von Barbara R Geraldino und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Engineering Department, Military Institute of Engineering (IME), Praça General Tibúrcio 80, Urca, Rio de Janeiro 22290-270, RJ, Brazil. Hauptthemen laut MEDLINE: Biosensing Techniques, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nano-carbon biointerfaces offer versatile platforms for cancer biomarker detection, but their progression from analytical proof-of-concept to clinically usable diagnostic evidence remains uneven. This scoping review maps 191 primary studies published from 2024 to 2026, covering nano-carbon families, surface chemistries, transduction architectures, biological matrices, and translational endpoints in cancer biosensing. The evidence space spans four nano-carbon dimensional classes: zero-dimensional carbon dots and quantum dots, one-dimensional carbon nanotubes, two-dimensional graphene-derived materials, and three-dimensional hybrid composites. Across these platforms, analytical sensitivity did not scale monotonically with nano-carbon dimensionality; instead, performance was shaped by the interaction between material architecture, biointerface chemistry, recognition strategy, transduction modality, and matrix context. A Translational Readiness Matrix showed that approximately 67% of studies remained at Low Evidence Level, whereas only approximately 10% reached Strong Evidence Level. Five recurring bottlenecks constrained translation: incomplete reproducibility reporting, limited Real-matrix Validation, scarce comparator-based clinical evidence, insufficient manufacturing-scale data, and weak regulatory or deployment planning. To address these gaps, this review proposes a nine-item minimum reporting checklist and a four-stage validation roadmap to support more reproducible, comparable, and clinically oriented nano-carbon biosensor development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesNeoplasmsHumansNanotubes, CarbonCarbon NanomaterialsCarbon Quantum DotsCarbon

Stichwörter der Autor:innen

biointerfacescancer diagnosticsclinical translationlimit of detectionnano-carbon biosensorsnanomaterialsregulatory pathwayscoping reviewtranslational readiness

Substanzen

Nanotubes, CarbonCarbon

Autor:innen und Institutionen

  • Nuclear Engineering Department, Military Institute of Engineering (IME), Praça General Tibúrcio 80, Urca, Rio de Janeiro 22290-270, RJ, Brazil.
  • Brazilian Army Command and General Staff College (ECEME), Praça General Tibúrcio, 125, Urca, Rio de Janeiro 22290-270, RJ, Brazil.
  • PENSI Institute (PENSI), Avenida Angélica, São Paulo 01228-200, SP, Brazil.
  • Universidade do Estado do Rio de Janeiro (UERJ), Rua São Francisco Xavier, 524, Maracanã, Rio de Janeiro 20550-900, RJ, Brazil.

ORCID-Profile: Barbara R Geraldino, Nilséia A Barbosa, Tatiana Cunha, Fernando M Araújo-Moreira

Zitieren

APA

Geraldino, B. R., Barbosa, N. A., Galdino, P. M., Migon, E. X. F. G., Godoy, D., Cunha, T., & Araújo-Moreira, F. M. (2026). Nano-Carbon Biointerfaces in Biosensors for Cancer: A Scoping Review Mapping the Transition from Proof-of-Concept to Translational Applicability (2024–2026). Biosensors, 16(7), 395. https://doi.org/10.3390/bios16070395

Vancouver

Geraldino BR, Barbosa NA, Galdino PM, Migon EXFG, Godoy D, Cunha T, et al. Nano-Carbon Biointerfaces in Biosensors for Cancer: A Scoping Review Mapping the Transition from Proof-of-Concept to Translational Applicability (2024–2026). Biosensors. 2026;16(7):395. doi:10.3390/bios16070395

BibTeX
@article{Geraldino2026,
  author = {Geraldino, Barbara R and Barbosa, Nilséia A and Galdino, Priscila M and Migon, Eduardo X F G and Godoy, Danielle and Cunha, Tatiana and Araújo-Moreira, Fernando M},
  title = {Nano-Carbon Biointerfaces in Biosensors for Cancer: A Scoping Review Mapping the Transition from Proof-of-Concept to Translational Applicability (2024–2026)},
  journal = {Biosensors},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {395},
  doi = {10.3390/bios16070395}
}
Kostenlos starten →